8
Total investments
2
Early stage
3
Mid stage
3
Late stage
7y
Years active
Portfolio
8 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Investor
Jul 2024
Keysom develops RISC-V based processor architectures that are automatically built from the application source code and dynamically reconfigurable, thanks to Keysom EDA.
Investor
2024
We are HawkCell, and we act now.
Were on a mission to make the healthcare industry more efficient and sustainable. We do this one animal MRI image at a time with a patented plug-and-play solution turning human MRI into an animal-dedicated one for veterinary clinics and preclinical research labs.
Were a young company, but were well on our way to becoming the undisputed leader in animal imaging. After consolidating our presence in Europe, we have the ambition to expand rapidly to the United States and Asia and become the undisputed leader of MRI for animals. Today, HawkCell is the only player offering augmented MRI solutions with strategic partnerships with the leading MRI manufacturers. In 2022, our playing field is a serviceable obtainable market (SOM) evaluated at 700 million USD… a market growing at double digits YoY.
We believe theres a better way to do healthcare, better for everyone — animals and humans.
Visit our website www.hawkcell.com and join us in our ambitious mission.
Investor/ Board Member
2023
Caeli Energie is a DeepTech startup designing and manufacturing new generation air conditioners: high energy efficiency and low carbon footprint.
Investor/ Board Observer
2023
Créée en 2018, Mob-Energy est une PME lyonnaise innovante qui développe et commercialise des solutions de recharge pour véhicules électriques.
Le robot chargeur « Charles », première innovation de Mob-Energy a remporté de nombreux prix et convaincus plusieurs grands-comptes. La nouvelle solution « Eiko » propose une approche inédite de la recharge avec un concept « plug and play » qui permet désormais de couvrir tous les cas d’usage des besoins clients en divisant par 10 la puissance à allouer à lIRVE.
Investor/ Board Observer
2023
MYCOPHYTO apporte des solutions concrètes pour une agriculture régénératrice. Lentreprise, créée en 2017, développe des solutions biologiques uniques de régénération des sols pour réduire les apports deau et dengrais chimiques (jusquà 20% de réduction deau et dengrais de synthèse) grâce à l’optimisation d’associations entre les plantes et des champignons mycorhiziens adaptés à chaque territoire et à chaque culture.
Prendre soin de nos sols et les rendre résilients, cest assurer la pérennité de notre alimentation !
Dans un contexte géopolitique instable où la souveraineté alimentaire est une priorité, travailler sur des stratégies de décarbonation des engrais est une nécessité. Grâce à un savoir-faire unique basé sur la connaissance des champignons mycorhiziens arbusculaires avec une Biobanque, un système de production breveté et un système dinformation prédictif alliant biotechnologie, big data et intelligence artificielle, MYCOPHYTO propose une solution naturelle unique.
La mycorhization est une symbiose entre un champignon microscopique du sol et une plante. Grâce à cette association, la plante peut capter leau plus facilement, avoir un accès privilégié aux éléments nutritifs et résister plus efficacement à de nombreux stress. Ce cercle vertueux ré enrichit les sols et rend les productions plus durables et résilientes.
Investor/ Board Member
2022
FinX développe & commercialise une technologie innovante de propulsion nautique, qui remplace les hélices des bateaux par des nageoires compactes et efficaces.
VC Investor
May 2020
Bpifrance, Banque publique dinvestissement, accompagne les entreprises, de lamorçage jusquà la cotation en bourse, du crédit aux fonds propres.
Interlocuteur privilégié, Bpifrance propose dans chaque région des solutions de financement ou d’investissement adaptées à chaque étape de la vie des entreprises.
Banque partenaire des entrepreneurs, Bpifrance les accompagne durablement pour soutenir leur croissance et leur compétitivité. Les équipes sont au cœur des régions, sur l’ensemble du territoire, à travers plus de 50 implantations régionales.
Chargée d'investissement
Oct 2019
Miarakap est lacteur pionnier du blended finance à destination des entrepreneurs à Madagascar.
Créé en 2018, il a développé trois gammes dactivités complémentaires :
- Linvestissement en capital et laccompagnement de PME à fort potentiel de croissance et dimpact, dont les besoins en fonds propres se situent entre 100 millions et 2 milliards MGA;
- La gestion de programmes de financement, daccompagnement et de promotion dentrepreneurs à impacts sociaux et environnementaux, financés par des bailleurs de fonds internationaux;
- Le conseil auprès dacteurs du Développement pour concevoir et mettre en oeuvre des programmes de soutien à lentrepreneuriat.
Experience · 11 entries
All (11)
Investments (8)
Founder (1)
Board (4)
2025
Principal
Mar 2025
ISAI is the 1st French Tech & Digital Investment Fund co-founded in 2009 by successful Tech entrepreneurs (Pierre Kosciusko Morizet, Geoffroy Roux de Bézieux, Stéphane Treppoz, etc) and backed by 300+ Entrepreneurs’ LP and major institutional investors.
Holding close its core values of Entrepreneurship, Honesty and Caring, ISAI is a team of 22 professionals based in Paris and NYC who all share the same guiding values of entrepreneurial success. The company is majority-owned by its employees. It keeps entrepreneurship at its heart and focuses on delivering excellent investment performance to its investor base.
ISAI currently manages €550m of assets through four pillars of investment expertise: Early-Stage Venture Capital, Late Stage Venture Capital, Private Debt and Growth / Buyout. It is a household name associated with recognized Tech & Digital successes: Blablacar, 360Learning, Labelium, LegalStart, Theodo, aDvens, Copado, Alation, DataDome, Malt, Prose, StickyAds, Evaneos, etc.
Co-Founder
Jan 2025
ISEP Transition & Climat – Le club des Alumni, étudiants et membres de l’ISEP qui veulent sengager pour la transition environnementale. 🌍💡
Rejoignez-nous pour échanger, partager des expériences et co-créer du contenu autour des enjeux écologiques dans le numérique. Ensemble, donnons-nous les moyens d’agir ! 🚀♻️
2024
Senior Associate
Sep 2024
Shift4Good is an impact venture capital fund with €220 million in assets under management, focused on the decarbonization of the transportation sector. We invest in the transport for goods and people, which alone accounts for around 25% of global CO2 emissions.
With a global presence from day one, we support the long-term success of category-defining startups and make them worldwide or regional champions.
With decades of experience in mobility, transportation, and cross-border expansion, Shift4Goods ecosystem includes a global network of experts and industry leaders - allowing us to closely partner with startups and drive better outcomes.
Additional info:
- Focus on Series A and Series B rounds
- Investment Ticket Size: between US$4m and US$20m per company.
- Geographies: With teams based in Paris and Singapore, we mostly focus on European and Southeast Asian opportunities.
- Our equity-only funds are backed by corporate, institutional, and private investors who genuinely understand the urgency of the environmental crisis we are in.
Investor
Jul 2024
Keysom develops RISC-V based processor architectures that are automatically built from the application source code and dynamically reconfigurable, thanks to Keysom EDA.
Investor
2024
We are HawkCell, and we act now.
Were on a mission to make the healthcare industry more efficient and sustainable. We do this one animal MRI image at a time with a patented plug-and-play solution turning human MRI into an animal-dedicated one for veterinary clinics and preclinical research labs.
Were a young company, but were well on our way to becoming the undisputed leader in animal imaging. After consolidating our presence in Europe, we have the ambition to expand rapidly to the United States and Asia and become the undisputed leader of MRI for animals. Today, HawkCell is the only player offering augmented MRI solutions with strategic partnerships with the leading MRI manufacturers. In 2022, our playing field is a serviceable obtainable market (SOM) evaluated at 700 million USD… a market growing at double digits YoY.
We believe theres a better way to do healthcare, better for everyone — animals and humans.
Visit our website www.hawkcell.com and join us in our ambitious mission.
Show all 11 entries ↓
Investment activity
2019–2024 · 8 investments
Recent (last 2 years)Earlier
